CPTAC Melanoma Baseline Form

Preferred Label : CPTAC Melanoma Baseline Form;

NCI Metathesaurus CUI : CL951273;

Details

Origin ID

C159415;

UMLS CUI

C5204413;

Semantic type(s)
- Intellectual Product [UMLS semantic type]
subset_includes_concept
- AJCC Cancer Staging Manual 7th Edition [NCIt concept]
- AJCC Cancer Staging Manual 8th Edition [NCIt concept]
- Ancillary Study [NCIt concept]
- Are Tumor Infiltrating Lymphocytes Present [NCIt concept]
- BRAF Gene Mutation [NCIt concept]
- BRAF Gene Mutation Negative [NCIt concept]
- BRAF Mutation Analysis Testing Method [NCIt concept]
- BRAF Mutation Analysis Was Not Performed [NCIt concept]
- BRAF Mutation Analysis Was Performed [NCIt concept]
- BRAF NM_004333.4:c.1798_1799delinsAA [NCIt concept]
- BRAF NM_004333.4:c.1798_1799delinsAG [NCIt concept]
- BRAF NM_004333.4:c.1799T>A [NCIt concept]
- BRAF NM_004333.4:c.1799_1800delinsAT [NCIt concept]
- Biospecimen Submitted to BCR [NCIt concept]
- Breslow Thickness [NCIt concept]
- CDR Entry Completed by (signature) [NCIt concept]
- CPTAC Case Identifier [NCIt concept]
- Centimeter [NCIt concept]
- Clark Level Finding [NCIt concept]
- Clark Level I [NCIt concept]
- Clark Level II [NCIt concept]
- Clark Level III [NCIt concept]
- Clark Level IV [NCIt concept]
- Clark Level V [NCIt concept]
- Comment [NCIt concept]
- Confirm AJCC/TNM Cancer Staging Edition [NCIt concept]
- Cutaneous Melanoma Clinical Distant Metastasis TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma Pathologic Distant Metastasis TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma Pathologic Primary Tumor TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma Pathologic Regional Lymph Nodes TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma by AJCC v8 Pathologic Stage [NCIt concept]
- Cutaneous Melanoma cM0 TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma cM1 TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma cM1a TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma cM1b TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma cM1c TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma pM1 TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma pM1a TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma pM1b TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma pM1c TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma pN0 TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma pN1 TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma pN1a TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma pN2 TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma pN2a TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma pN2c TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma pN3 TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma pNX TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma pT0 TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma pT1 TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma pT1a TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma pT1b TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma pT2 TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma pT2a TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma pT2b TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma pT3 TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma pT3a TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma pT3b TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma pT4 TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma pT4a TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma pT4b TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma pTX TNM Finding v8 [NCIt concept]
- Cutaneous Melanoma pTis TNM Finding v8 [NCIt concept]
- Did the Individual have Multiple Known Primary Tumors at Initial Melanoma Diagnosis [NCIt concept]
- Distant Metastasis [NCIt concept]
- ECOG Performance Status 0 [NCIt concept]
- ECOG Performance Status 1 [NCIt concept]
- ECOG Performance Status 2 [NCIt concept]
- ECOG Performance Status 3 [NCIt concept]
- ECOG Performance Status 4 [NCIt concept]
- ECOG Performance Status not Evaluated, not Provided or Available [NCIt concept]
- Extranodal Involvement [NCIt concept]
- Extranodal Tumor Extension Absent [NCIt concept]
- Form Completed by (Signature) [NCIt concept]
- Greatest Dimension Tumor [NCIt concept]
- Growth Phase [NCIt concept]
- Head and Neck [NCIt concept]
- Histologic Subtype [NCIt concept]
- Histologic Type [NCIt concept]
- IHC Staining not Done [NCIt concept]
- If Other Edition, Specify [NCIt concept]
- If Other, Specify [NCIt concept]
- Immunohistochemistry Was Not Performed [NCIt concept]
- Immunohistochemistry Was Performed [NCIt concept]
- Incomplete Staging (cM) [NCIt concept]
- Incomplete Staging (pM) [NCIt concept]
- Indeterminate Extranodal Tumor Extension [NCIt concept]
- Indeterminate Growth Phase [NCIt concept]
- Indeterminate Lymph-Vascular Invasion [NCIt concept]
- Indeterminate Macroscopic Satellite Nodule [NCIt concept]
- Indeterminate Microsatellite Instability [NCIt concept]
- Indeterminate Peri-Neural Invasion [NCIt concept]
- Indeterminate Tumor Regression [NCIt concept]
- Indeterminate Ulceration [NCIt concept]
- Initial Cancer Diagnosis Date [NCIt concept]
- Interferon Gamma Treatment Administration 90 Days Prior to Specimen Resection Unknown [NCIt concept]
- Interferon Gamma Treatment was Administered 90 Days Prior to Specimen Resection [NCIt concept]
- Interferon Gamma Treatment was Administered Prior to Specimen Resection [NCIt concept]
- Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection [NCIt concept]
- Interferon Gamma Treatment was not Administered Prior to Specimen Resection [NCIt concept]
- Is Another BRAF Mutation Present [NCIt concept]
- Is Another KIT Mutation Present [NCIt concept]
- Is Another NRAS Mutation Present [NCIt concept]
- Is Extranodal Tumor Involvement Present [NCIt concept]
- Is Macroscopic Satellite Nodule Present [NCIt concept]
- Is Microsatellitosis Present [NCIt concept]
- Is Paraneoplastic Syndrome Present [NCIt concept]
- Is Tumor Cell Necrosis Present [NCIt concept]
- Is Tumor Regression Present [NCIt concept]
- KIT Gene Mutation [NCIt concept]
- KIT Gene Mutation Negative [NCIt concept]
- KIT Mutation Analysis Testing Method [NCIt concept]
- KIT Mutation Analysis Was Not Performed [NCIt concept]
- KIT Mutation Analysis Was Performed [NCIt concept]
- KIT NM_000222.2:c.1669T>A [NCIt concept]
- KIT NM_000222.2:c.1676T>C [NCIt concept]
- KIT NM_000222.2:c.1727T>C [NCIt concept]
- KIT NM_000222.2:c.1924A>G [NCIt concept]
- Karnofsky Performance Status 0 [NCIt concept]
- Karnofsky Performance Status 10 [NCIt concept]
- Karnofsky Performance Status 100 [NCIt concept]
- Karnofsky Performance Status 20 [NCIt concept]
- Karnofsky Performance Status 30 [NCIt concept]
- Karnofsky Performance Status 40 [NCIt concept]
- Karnofsky Performance Status 50 [NCIt concept]
- Karnofsky Performance Status 60 [NCIt concept]
- Karnofsky Performance Status 70 [NCIt concept]
- Karnofsky Performance Status 80 [NCIt concept]
- Karnofsky Performance Status 90 [NCIt concept]
- Karnofsky Performance Status Not Evaluated [NCIt concept]
- Karnofsky Performance Status Unknown [NCIt concept]
- Limb [NCIt concept]
- Lymphatic Invasion Absent [NCIt concept]
- Lymphatic Invasion is Present [NCIt concept]
- Macroscopic Satellite Nodule Not Identified [NCIt concept]
- Macroscopic Satellite Nodule is Present [NCIt concept]
- Margin Involved by Invasive Melanoma [NCIt concept]
- Margin Status Cannot be Assessed [NCIt concept]
- Margin Uninvolved by Invasive Melanoma [NCIt concept]
- Melanoma [NCIt concept]
- Melanoma Involvement of Regional Cutaneous or Subcutaneous Tissue [NCIt concept]
- Microsatellitosis [NCIt concept]
- Microsatellitosis Absent [NCIt concept]
- Millimeter [NCIt concept]
- Mitotic Activity [NCIt concept]
- Mitotic Rate Greater than or Equal to One per Square Millimeter [NCIt concept]
- Mitotic Rate Less than One per Square Millimeter [NCIt concept]
- Month-Day-Year [NCIt concept]
- Multifocal Lesion [NCIt concept]
- Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis [NCIt concept]
- Multiple Known Primary Tumors Present at Initial Melanoma Diagnosis [NCIt concept]
- Multiple Known Primary Tumors Unknown at Initial Melanoma Diagnosis [NCIt concept]
- NRAS Gene Mutation Negative [NCIt concept]
- NRAS Mutation Analysis [NCIt concept]
- NRAS Mutation Analysis Testing Method [NCIt concept]
- NRAS Mutation Analysis Was Not Performed [NCIt concept]
- NRAS Mutation Analysis Was Performed [NCIt concept]
- NRAS NM_002524.4:c.181C>A [NCIt concept]
- NRAS NM_002524.4:c.182A>G [NCIt concept]
- NRAS NM_002524.4:c.182A>T [NCIt concept]
- NRAS NM_002524.4:c.183A>T [NCIt concept]
- NRAS NM_002524.4:c.34G>A [NCIt concept]
- NRAS NM_002524.4:c.34G>C [NCIt concept]
- NRAS NM_002524.4:c.35G>A [NCIt concept]
- NRAS NM_002524.4:c.35G>T [NCIt concept]
- NRAS NM_002524.4:c.37G>A [NCIt concept]
- NRAS NM_002524.4:c.37G>C [NCIt concept]
- No Pathologic Evidence of Distant Metastasis [NCIt concept]
- None Identified [NCIt concept]
- Not Known if BRAF Mutation Analysis Was Performed [NCIt concept]
- Not Known if Immunohistochemistry Was Performed [NCIt concept]
- Not Known if KIT Mutation Analysis Was Performed [NCIt concept]
- Not Known if NRAS Mutation Analysis Was Performed [NCIt concept]
- Number of Known Primaries at the Time of Initial Melanoma Diagnosis [NCIt concept]
- Number of Lymph Nodes Examined [NCIt concept]
- Number of Lymph Nodes Positive for Tumor by H&E [NCIt concept]
- Number of Lymph Nodes Positive for Tumor by IHC Staining Only [NCIt concept]
- Organ of Origin [NCIt concept]
- Other Edition [NCIt concept]
- Other Tumor Site [NCIt concept]
- Palms of Hands and Soles of Feet [NCIt concept]
- Paraneoplastic Syndrome Status is Unknown [NCIt concept]
- Paraneoplastic Syndrome is Not Present [NCIt concept]
- Paraneoplastic Syndrome is Present [NCIt concept]
- Pathologic Stage 0 Cutaneous Melanoma AJCC v8 [NCIt concept]
- Pathologic Stage IA Cutaneous Melanoma AJCC v8 [NCIt concept]
- Pathologic Stage IB Cutaneous Melanoma AJCC v8 [NCIt concept]
- Pathologic Stage IIA Cutaneous Melanoma AJCC v8 [NCIt concept]
- Pathologic Stage IIB Cutaneous Melanoma AJCC v8 [NCIt concept]
- Pathologic Stage IIC Cutaneous Melanoma AJCC v8 [NCIt concept]
- Pathologic Stage IIIA Cutaneous Melanoma AJCC v8 [NCIt concept]
- Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 [NCIt concept]
- Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 [NCIt concept]
- Pathologic Stage IV Cutaneous Melanoma AJCC v8 [NCIt concept]
- Perineural Invasion [NCIt concept]
- Perineural Invasion Absent [NCIt concept]
- Perineural Invasion Assessment [NCIt concept]
- Preoperative ECOG - Performance Status [NCIt concept]
- Preoperative Karnofsky Performance Status [NCIt concept]
- Primary Neoplasm [NCIt concept]
- Print, Sign, Date Form [NCIt concept]
- Radial Growth Phase [NCIt concept]
- Regional Lymph Node [NCIt concept]
- Residual Disease [NCIt concept]
- Select One [NCIt concept]
- Site of Tumor [NCIt concept]
- Specify [NCIt concept]
- Specify Number of Lymph Nodes Examined [NCIt concept]
- Specify Number of Lymph Nodes Positive for Tumor by H&E [NCIt concept]
- Specify Number of Lymph Nodes Positive for Tumor by IHC Staining Only [NCIt concept]
- Specify Other BRAF Mutation [NCIt concept]
- Specify Other KIT Mutation [NCIt concept]
- Specify Other NRAS Mutation [NCIt concept]
- Specify Other Tumor Site [NCIt concept]
- Specify Site If Distant Metastasis Submitted [NCIt concept]
- Specify Site if Documented Distant Metastasis [NCIt concept]
- Specify Site of Metastasis [NCIt concept]
- Specify Type of Testing and Results if Yes [NCIt concept]
- Specimen Source Site [NCIt concept]
- Stage R0 [NCIt concept]
- Stage R1 [NCIt concept]
- Stage R2 [NCIt concept]
- Stage RX [NCIt concept]
- Subungual [NCIt concept]
- Surgical Margins Status [NCIt concept]
- Tissue Source Site [NCIt concept]
- Tissue Source Site Identifier [NCIt concept]
- Transcribe Data into CDR and Record the Following [NCIt concept]
- Trunk [NCIt concept]
- Tumor Cell Necrosis is Present [NCIt concept]
- Tumor Focality [NCIt concept]
- Tumor Infiltrating Lymphocyte Absent [NCIt concept]
- Tumor Infiltrating Lymphocyte is Present [NCIt concept]
- Tumor Necrosis Not Identified [NCIt concept]
- Tumor Regression [NCIt concept]
- Tumor Regression Absent [NCIt concept]
- Ulceration [NCIt concept]
- Ulceration is Absent [NCIt concept]
- Ulceration is Present [NCIt concept]
- Unifocal Lesion [NCIt concept]
- Unknown Clark Level [NCIt concept]
- Unknown ECOG Performance Status [NCIt concept]
- Unknown if Interferon Gamma Treatment was Administered Prior to Specimen Resection [NCIt concept]
- Vertical Growth Phase [NCIt concept]
- Was Additional Testing Performed [NCIt concept]
- Was BRAF Mutation Analysis Performed [NCIt concept]
- Was Immunohistochemical Testing Performed [NCIt concept]
- Was Interferon Gamma Treatment Administered 90 Days Prior to Specimen Resection [NCIt concept]
- Was Interferon Gamma Treatment Administered Prior to Specimen Resection [NCIt concept]
- Was KIT Mutation Analysis Performed [NCIt concept]
- Was NRAS Mutation Analysis Performed [NCIt concept]
- Wild Type [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients